Hepcludex European Union - English - EMA (European Medicines Agency)

hepcludex

gilead sciences ireland uc - bulevirtide acetate - hepatitis d, chronic - antivirals for systemic use - hepcludex is indicated for the treatment of chronic hepatitis delta virus (hdv) infection in plasma (or serum) hdv-rna positive adult patients with compensated liver disease.

Sulpiride Grindeks 100 mg tablets Ireland - English - HPRA (Health Products Regulatory Authority)

sulpiride grindeks 100 mg tablets

as grindeks - sulpiride - tablet - sulpiride

Sulpiride Grindeks 200 mg tablets Ireland - English - HPRA (Health Products Regulatory Authority)

sulpiride grindeks 200 mg tablets

as grindeks - sulpiride - tablet - sulpiride

Sulpiride Grindeks 50 mg tablets Ireland - English - HPRA (Health Products Regulatory Authority)

sulpiride grindeks 50 mg tablets

as grindeks - sulpiride - tablet - sulpiride

Sulpiride EG 200 mg tabl. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sulpiride eg 200 mg tabl.

eg sa-nv - sulpiride 200 mg - tablet - 200 mg - sulpiride 200 mg - sulpiride

Sulpiride Grindeks 50 mg tabl. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sulpiride grindeks 50 mg tabl.

joint stock company grindeks - sulpiride 50 mg - tablet - 50 mg - sulpiride 50 mg - sulpiride

Sulpiride Grindeks 100 mg tabl. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sulpiride grindeks 100 mg tabl.

joint stock company grindeks - sulpiride 100 mg - tablet - 100 mg - sulpiride 100 mg - sulpiride

Sulpiride Grindeks 200 mg tabl. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sulpiride grindeks 200 mg tabl.

joint stock company grindeks - sulpiride 200 mg - tablet - 200 mg - sulpiride 200 mg - sulpiride

FUZEON- enfuvirtide kit United States - English - NLM (National Library of Medicine)

fuzeon- enfuvirtide kit

genentech, inc. - enfuvirtide (unii: 19owo1t3ze) (enfuvirtide - unii:19owo1t3ze) - enfuvirtide 90 mg in 1 ml - fuzeon® in combination with other antiretroviral agents is indicated for the treatment of hiv-1 infection in treatment-experienced patients with evidence of hiv-1 replication despite ongoing antiretroviral therapy. fuzeon is contraindicated in patients with known hypersensitivity to fuzeon or any of its components [see warnings and precautions (5.4)] . pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in individuals exposed to antiretroviral medicines during pregnancy. healthcare providers are encouraged to register patients by calling the antiretroviral pregnancy registry (apr) at 1-800-258-4263. risk summary prospective pregnancy data from the apr are not sufficient to adequately assess the risk of birth defects or fetal outcomes. limited number of reports on the use of enfuvirtide during pregnancy has been submitted to the apr and the number of exposures to enfuvirtide is insufficient to make a risk assessment compared to a reference population. all pregna

Sulpiride 200mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sulpiride 200mg tablets

medreich plc - sulpiride - oral tablet - 200mg